SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-22-000026
Filing Date
2022-01-04
Accepted
2022-01-04 07:39:26
Documents
12
Period of Report
2021-12-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tgtx-20211230x8k.htm   iXBRL 8-K 33549
  Complete submission text file 0001558370-22-000026.txt   155335

Data Files

Seq Description Document Type Size
2 EX-101.SCH tgtx-20211230.xsd EX-101.SCH 3357
3 EX-101.LAB tgtx-20211230_lab.xml EX-101.LAB 16029
4 EX-101.PRE tgtx-20211230_pre.xml EX-101.PRE 11027
6 EXTRACTED XBRL INSTANCE DOCUMENT tgtx-20211230x8k_htm.xml XML 4871
Mailing Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014 (212) 554-4484
TG THERAPEUTICS, INC. (Filer) CIK: 0001001316 (see all company filings)

IRS No.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32639 | Film No.: 22504075
SIC: 2834 Pharmaceutical Preparations